Fee for Using a Rare Pediatric Disease Priority Review Voucher in Fiscal Year 2016; Correction

---
identifier: "/us/fr/2015-25525"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Fee for Using a Rare Pediatric Disease Priority Review Voucher in Fiscal Year 2016; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2015-25525"
section_name: "Fee for Using a Rare Pediatric Disease Priority Review Voucher in Fiscal Year 2016; Correction"
positive_law: false
currency: "2015-10-07"
last_updated: "2015-10-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2015-25525"
document_type: "notice"
publication_date: "2015-10-07"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "80 FR 60687"
fr_volume: 80
docket_ids:
  - "Docket No. FDA-2015-N-0007"
fr_action: "Notice; correction."
---


#  Fee for Using a Rare Pediatric Disease Priority Review Voucher in Fiscal Year 2016; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a notice entitled “Fee for Using a Rare Pediatric Disease Priority Review Voucher in Fiscal Year 2016” that appeared in the *Federal Register* of September 28, 2015 (80 FR 58262). The document announced the fee rate for using a rare pediatric disease priority review voucher for fiscal year 2016. The document was published with the incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Lisa Granger, Food and Drug Administration, Bldg. 32, Rm. 3330, Silver Spring, MD 20993, 301-796-9115, *[email protected]* .

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 2015-24508, appearing on page 58262 in the *Federal Register* of Monday, September 28, 2015, the following correction is made:

On page 58262, in the third column, in the headings section of the document, “FDA-2014-N-0007” is corrected to read “FDA-2015-N-0007”.

Dated: October 2, 2015.

Jill Hartzler Warner,

Associate Commissioner for Special Medical Programs.